marico

Which companies are best placed to ride out the slowdown in consumption?

Ideas for Profit | Marico’s steady diversification adds to earnings visibility

Buy Marico; target of Rs 435: Arihant Capital

Arihant Capital is bullish on Marico has recommended buy rating on the stock with a target price of Rs 435 in its research report dated May 06, 2019.

Hold Marico; target of Rs 351: Prabhudas Lilladher

Prabhudas Lilladher recommended hold rating on Marico with a target price of Rs 351 in its research report dated May 06, 2019.

Buy Marico; target of Rs 425: ICICI Direct

ICICI Direct is bullish on Marico has recommended buy rating on the stock with a target price of Rs 425 in its research report dated May 07, 2019.

Buy Marico; target of Rs 425: Sharekhan

Sharekhan is bullish on Marico has recommended buy rating on the stock with a target price of Rs 425 in its research report dated May 06, 2019.

Buy Marico; target of Rs 425: Motilal Oswal

Motilal Oswal is bullish on Marico has recommended buy rating on the stock with a target price of Rs 425 in its research report dated May 06, 2019.

Accumulate Marico; target of Rs 388: Dolat Capital

Dolat Capital recommended accumulate rating on Marico with a target price of Rs 388 in its research report dated May 07, 2019.

Marico rallies over 7% as PAT zooms 2-fold; Macquarie raises target price

Macquarie maintained its outperform rating on Marico but raised its target price to Rs 412 from Rs 394 earlier.

Marico Q4 review: Volume growth on expected lines; improving margin profile key positive

Marico Consolidated March 2019 Net Sales at Rs 1,609.00 crore, up 8.71% Y-o-Y

Marico Standalone March 2019 Net Sales at Rs 1,290.00 crore, up 6.28% Y-o-Y

Godrej Consumer: Domestic business a tough nut to crack; stay on the sidelines

Marico to report Q4 earnings today; here's what brokerages are expecting

The pre-Q4FY19 commentary seems decent, while India business volume growth should be around 8 percent YoY, said CLSA.

ASCI pulls up Parle, Marico, Vivo, Amul among others

'The claims are misleading by exaggeration,' it said and asked the advertiser to take corrective steps or pull out the ad.

Marico Q4 PAT seen up 15.8% YoY to Rs. 212.2 cr: ICICI Direct

Net Sales are expected to increase by 16.7 percent Y-o-Y (down 7.2 percent Q-o-Q) to Rs. 1,726.8 crore, according to ICICI Direct.

Weekly Tactical Pick: Jyothy Laboratories

Jyothy Labs currently trades at 29 times estimated FY20 earnings, which is about 40 percent discount to the average of FMCG majors

Market Headstart: Nifty likely to open flat; 3 stocks which could give 4-7% return

Trends on SGX Nifty indicate a flat opening for the broader index in India, a slip of 1 point or 0.01 percent. Nifty futures were trading around 10,682-level on the Singaporean Exchange.

Weekly Tactical Pick | Marico: Improving margin profile make us constructive

The management expects operating margin to improve moderately as input costs have eased and operating leverage benefits are also expected to show

Buy Marico; target of Rs 425: Sharekhan

Sharekhan is bullish on Marico has recommended buy rating on the stock with a target price of Rs 425 in its research report dated April 03, 2019.

Marico Q4 update: Volume growth on expected lines; improving margin profile a key positive

Harsh Mariwala says slowdown in GDP an ‘aberration’, wants PM Modi to continue with reforms

Mariwala envisages India to grow faster than what it has grown in the past

'Mild profit-booking likely but bullish trend to continue, 11,600 to be upper band for the week'

FII strong inflow in the market has already lead to Rupee appreciation and we expect bullish trend to continue in the stock market & positive sentiments to remain strong.

What explains a relatively steady show by the FMCG companies?

FMCG is a bright spot in consumption; how investors can play this theme

We continue to prefer companies that focus on distribution reach, and deploy internal accruals to invest behind their brands. A sustainable way of doing the latter is deploying internal accruals such as cost savings and utilizing super normal profit from other product groups.